Expanding Medicare coverage of anti-obesity medicines could increase annual spending by $3.1 to $6.1 billion, according to a new Health Affairs study.
Category: Disease management, Financial management, Payers, Behavioral health, Healthy aging, Pharma, Health and Wellness, Finance, Life Sciences
